NEW YORK (GenomeWeb News) – Meridian Bioscience today said that its fiscal fourth-quarter sales rose 6 percent year over year with its molecular diagnostic business contributing to the growth.

For the three months ended Sept. 30, the company posted $43.7 million in revenues, compared to $41.3 million a year ago, beating the consensus analyst estimate of $43.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.